Clinical trial
Efficacy of Immunomudulatory Therapy With All-trans Retinoid Acid for Adults With Chronic Immune Thrombocytopenia
NCT01668615 is registered in ClinicalTrials.gov with First Affiliated Hospital of Suzhou Medical College as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Immunomudulatory Therapy With All-trans Retinoid Acid for Adults With Chronic Immune Thrombocytopenia
- Lead sponsor
- First Affiliated Hospital of Suzhou Medical College
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2011
- Completion date
- August 31, 2012
- Enrollment
- 35 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
immune thrombocytopenic purpura